bioMérieux : Amélioration d’ensemble sur le 1er semestre 2020 – Achat vs Neutre – OC relevé à 96 €
>Vers une saison grippale positive pour BioFire ? - Les différents organes de surveillance de la pathologie grippale (ECDC et CDC) nous apportent des signaux récents intéressants, en particulier aux USA (80% des ventes de FilmArray®) pour BioFire dont les ventes devraient, notamment au T1 2020, bénéficier d’un effet de base favorable. La croissance de FilmArray® devrait garder un cap proche de 25%. Le principal moteur de croissance du groupe dispose d’un potentie...Co. specializes in the field of in vitro diagnostics for clinical and industrial applications. Co. designs, develops, manufactures and markets systems used in: Clinical Applications (the diagnosis of infectious diseases such as hepatitis, HIV, tuberculosis and respiratory illnesses, as well as pathologies such as cardiovascular diseases and cancers, based on the analysis of biological samples such as blood, saliva or urine); and Industrial Applications (microbiological analysis of samples of finished or semi-finished products (or of the environment), chiefly in the food processing and biopharmaceutical industries), detecting microorganisms in agri-food, pharmaceutical and cosmetic products.
Oddo Securities provides securities brokerage and research services. The company offers equity, economic, and derivatives research and credit analysis services. It focuses on insurance, automotive, building materials, pharmaceuticals, telecommunications, information technology, and agri-food industries.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.